tiprankstipranks
Trending News
More News >

iX Biopharma Ltd. Conducts Extraordinary General Meeting

Story Highlights
iX Biopharma Ltd. Conducts Extraordinary General Meeting

Don’t Miss TipRanks’ Half-Year Sale

The latest announcement is out from iX Biopharma Ltd. ( (SG:42C) ).

iX Biopharma Ltd. held an Extraordinary General Meeting (EGM) on March 10, 2025, chaired by Mr. Eddy Lee Yip Hang. The meeting included the Board of Directors and shareholders, with voting conducted by poll. The meeting proceeded without any questions from shareholders, and all motions were proposed by the Chairman.

More about iX Biopharma Ltd.

iX Biopharma Ltd. is a company incorporated in Singapore, operating within the biopharmaceutical industry. The company focuses on developing and commercializing innovative therapies and products, leveraging its proprietary sublingual drug delivery technology.

YTD Price Performance: 5.00%

Average Trading Volume: 298,678

Technical Sentiment Signal: Buy

Current Market Cap: S$18.59M

See more data about 42C stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1